Click here for the CME evaluation / post-test
Activity Index
Click on the titles below to view the presentations.
The mechanism of CTLA-4 activity and negative regulation of T cell activation
Jedd D. Wolchok, MD, PhD
Overcoming immunologic tolerance to melanoma: Targeting CTLA-4 with Tremelimumab
Antoni Ribas, MD
Overcoming immunologic tolerance to melanoma: Targeting CTLA-4 with Ipilimumab
Jeffrey S. Weber, MD, PhD
Click here for the CME evaluation / post-test
|
